Pivoting health research to take on COVID-19 - What one team learned

Colorized scanning electron micrograph of apoptotic cell infected with novel coronavirus Image: via REUTERS

Daniel P. Oran

Associate Director, Scripps Research Translational Institute

Jennifer M. Radin

Senior Staff Scientist, Scripps Research Translational Institute

Steven R. Steinhubl

Director of Digital Medicine, Scripps Research Translational Institute, Staff Cardiologist, Alaska Native Tribal Health Consortium


Our Impact
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:



What is the World Economic Forum doing about the coronavirus outbreak?

Daniel P. Oran, Jennifer M. Radin, Steven R. Steinhubl

Have you read?

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

COVID-19Global Health


Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda


You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

COVID-19 variants: Will existing rapid antigen tests be able to detect new strains?
About Us
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum